The U.S. Food and Drug Administration banned imports from one of the plants of Indian drug maker Wockhardt, in the latest example of increased global scrutiny of Indian generic drug makers.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223811724316666.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304747004579223811724316666.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento